Trial intelligence / Profile preview

Biomarkers and antithrombotic treatment in cervical artery dissection

2015-003200-23Phase 4Completed

Sponsor
University Hospital Basel
Start
Jan 2016
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in cervical artery dissection comparing Acetylsalicylic acid arm with Phenprocoumon (vitamin K antagonist) arm (2 arms). Primary endpoint: Primary composite outcome CIHD. Started Jan 2016; status: completed.

02

Drugs

aspirinphenprocoumon
03

Conditions

cervical artery dissection

Beyond the preview

Go deeper on 2015-003200-23.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-003200-23.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call